M Ingelmo

15.8k total citations · 2 hit papers
158 papers, 9.2k citations indexed

About

M Ingelmo is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, M Ingelmo has authored 158 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Rheumatology, 32 papers in Immunology and 30 papers in Pathology and Forensic Medicine. Recurrent topics in M Ingelmo's work include Systemic Lupus Erythematosus Research (86 papers), Salivary Gland Disorders and Functions (24 papers) and Systemic Sclerosis and Related Diseases (23 papers). M Ingelmo is often cited by papers focused on Systemic Lupus Erythematosus Research (86 papers), Salivary Gland Disorders and Functions (24 papers) and Systemic Sclerosis and Related Diseases (23 papers). M Ingelmo collaborates with scholars based in Spain, Mexico and United Kingdom. M Ingelmo's co-authors include Ricard Cervera, Josep Font, Manuel Ramos‐Casals, Mario García‐Carrasco, Munther A. Khamashta, Gerard Espinosa, Joan Carles Reverter, Alfonso López‐Soto, Ronald A. Asherson and Enrique de Ramón and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Kidney International.

In The Last Decade

M Ingelmo

151 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period

2003 987 citations Ricard Cervera, Munther A. Khamashta et al. Medicine profile →
Systemic Lupus Erythematosus

1993 706 citations Ricard Cervera, Munther A. Khamashta et al. Medicine profile →

Peers

Countries citing papers authored by M Ingelmo

Since Specialization

Citations

This map shows the geographic impact of M Ingelmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ingelmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ingelmo more than expected).

Fields of papers citing papers by M Ingelmo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Ingelmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ingelmo. The network helps show where M Ingelmo may publish in the future.

Co-authorship network of co-authors of M Ingelmo

This figure shows the co-authorship network connecting the top 25 collaborators of M Ingelmo. A scholar is included among the top collaborators of M Ingelmo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Ingelmo. M Ingelmo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vasculitis in Systemic Lupus Erythematosus 2006 ·Medicine ·Manuel Ramos‐Casals, Norma Nardi, Mariana Lagrutta, Pilar Brito‐Zerón, Albert Bové, (unknown), Ricard Cervera, M Ingelmo, Josep Font	124
2	Circulating Monoclonal Immunoglobulins in Sjögren Syndrome 2005 ·Medicine ·Pilar Brito‐Zerón, Manuel Ramos‐Casals, Norma Nardi, Ricard Cervera, Jordi Yagüe, M Ingelmo, Josep Font	39
3	Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome 2005 ·Annals of the Rheumatic Diseases ·Ricard Cervera, Josep Font, José A. Gómez‐Puerta, Gerard Espinosa, M Cucho, S. Bucciarelli, Manuel Ramos‐Casals, M Ingelmo, J.C. Pietté, Y Shoenfeld, R A Asherson	163
4	Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: A prospective, long-term, followup study 2005 ·Arthritis & Rheumatism ·Félix Pérez‐Villa, Josep Font, Manel Azqueta, Gerard Espinosa, Carles Paré, Ricard Cervera, Joan Carles Reverter, M Ingelmo, Ginés Sanz	64
5	Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period breakdown → 2003 ·Medicine ·Ricard Cervera, Munther A. Khamashta, Josep Font, Gian Domenico Sebastiani, (unknown), Paz Lavilla, Juan Carlos Mejía, AO. Aydintug, H Chwalińska-Sadowska, Enrique de Ramón, Antonio Fernández‐Nebro, Mauro Galeazzi, (unknown), Alessandro Mathieu, Frédéric Houssiau, N Caro, Paula Alba, Manuel Ramos‐Casals, M Ingelmo, Graham Hughes	987
6	Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients. 2002 ·PubMed ·Mario García‐Carrasco, Antoni Sisó‐Almirall, Manuel Ramos‐Casals, J. Rosas, Gloria de la Red, Víctor Gil, (unknown), Ricard Cervera, Josep Font, M Ingelmo	46
7	Vascular involvement in Behçet’s disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin 2002 ·The American Journal of Medicine ·Gerard Espinosa, Josep Font, Dolors Tàssies, Antonio Vidaller, R. Deulofeu, Alfons López‐Soto, Ricard Cervera, A Ordinas, M Ingelmo, Joan Carles Reverter	124
8	Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection 2002 ·Seminars in Arthritis and Rheumatism ·Manuel Ramos‐Casals, Mario García‐Carrasco, Ricard Cervera, Xavier Filella, Olga Trejo, Gloria de la Red, Víctor Gil, José M. Sánchez–Tapias, Josep Font, M Ingelmo	37
9	Myelodysplastic and Myeloproliferative Syndromes Associated with Giant Cell Arteritis and Polymyalgia Rheumatica: A Coincidental Coexistence or a Causal Relationship? 2002 ·Clinical Rheumatology ·Gerard Espinosa, Josep Font, Francisco J. Muñoz, Ricard Cervera, M Ingelmo	43
10	The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome 2000 ·Arthritis & Rheumatism ·Dolors Tàssies, Gerard Espinosa, Francisco J. Muñoz, (unknown), Ricard Cervera, Joan Monteagudo, S Maragall, Ginés Escolar, M Ingelmo, A Ordinas, Josep Font, Joan Carles Reverter	60
11	Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients 1999 ·Medicine ·Ricard Cervera, Munther A. Khamashta, Josep Font, Gian Domenico Sebastiani, (unknown), Paz Lavilla, AO. Aydintug, Anna Jędryka-Góral, Enrique de Ramón, Antonio Fernández‐Nebro, Mauro Galeazzi, Hans‐Jacob Haga, Alessandro Mathieu, Frédéric Houssiau, Guillermo Ruiz‐Irastorza, M Ingelmo, Graham Hughes	315
12	Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients 1998 ·Medicine ·Ronald A. Asherson, Ricard Cervera, Jean‐Charles Piette, Josep Font, J. T. Lie, (unknown), (unknown), Francisco J. Muñoz, Roger A. Levy, François Boué, Jérôme Rossert, M Ingelmo	369
13	Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes 1998 ·Arthritis & Rheumatism ·Joan Carles Reverter, Dolors Tàssies, Josep Font, Munther A. Khamashta, Kenji Ichikawa, Ricard Cervera, Ginés Escolar, Graham Hughes, M Ingelmo, A Ordinas	84
14	Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults 1998 ·Annals of the Rheumatic Diseases ·Josep Font, Ricard Cervera, Gerard Espinosa, L Pallarés, Manuel Ramos‐Casals, Sònia Jiménez, Mario García‐Carrasco, (unknown), M Ingelmo	222
15	Hepatitis C virus infection in ‘primary’ Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients 1997 ·Annals of the Rheumatic Diseases ·Mario García‐Carrasco, María Dolores Burguete Ramos, Ricard Cervera, Josep Font, Josép Vidal, Francisco J. Muñoz, C Miret, Gerard Espinosa, M Ingelmo	68
16	Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome 1997 ·Lara D. Veeken ·Montserrat Teixidó, Josep Font, Joan Carles Reverter, Ricard Cervera, Dolors Tàssies, M Ingelmo, Ginés Escolar, A Ordinas	30
17	Systemic Lupus Erythematosus breakdown → 1993 ·Medicine ·Ricard Cervera, Munther A. Khamashta, Josep Font, Gian Domenico Sebastiani, Antonio Gil‐Moreno, Paz Lavilla, Ines Domenech, AO. Aydintug, Anna Jędryka-Góral, Enrique de Ramón, Mauro Galeazzi, Hans‐Jacob Haga, Alessandro Mathieu, Frédéric Houssiau, M Ingelmo, Graham R.V. Hughes	706
18	Pregnancy: Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome 1993 ·Human Reproduction ·Juan Balasch, (unknown), Alfonso López‐Soto, José A. Font, Montserrat Creus, Francisco Fábregues, M Ingelmo, Juan A. Vanrell	58
19	Prosthetic valve endocarditis caused by corynebacterium pilosum 1991 ·Infection ·José A. Sobrino, (unknown), Esteban Poch, M Ingelmo, (unknown), José M. Miró, Josep Antoni Bombí	3
20	Systemic lupus erythematosus in a patient with partial lipodystrophy 1990 ·Journal of the American Academy of Dermatology ·Josep Font, Carmen Herrero, Xavier Bosch, Ricard Cervera, M Ingelmo, José M. Mascaró	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact